Rab3a promotes brain tumor initiation and progression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jun-Kyum | - |
dc.contributor.author | Lee, Seung-Yup | - |
dc.contributor.author | Park, Chang-Won | - |
dc.contributor.author | Park, Suk-Hwang | - |
dc.contributor.author | Yin, Jinlong | - |
dc.contributor.author | Kim, Jaebong | - |
dc.contributor.author | Park, Jae-Bong | - |
dc.contributor.author | Lee, Jae-Yong | - |
dc.contributor.author | Kim, Hyunggee | - |
dc.contributor.author | Kim, Sung-Chan | - |
dc.date.accessioned | 2021-09-05T05:33:04Z | - |
dc.date.available | 2021-09-05T05:33:04Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-09 | - |
dc.identifier.issn | 0301-4851 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97465 | - |
dc.description.abstract | The Rab protein family is composed of small GTP-binding proteins involved in intracellular vesicle trafficking. In particular, Rab3a which is one of four Rab3 proteins (a, b, c, and d isoforms) is associated with synaptic vesicle trafficking in normal brain. However, despite the elevated level of Rab3a in tumors, its role remains unclear. Here we report a tumorigenic role of Rab3a in brain tumors. Elevated level of Rab3a expression in human was confirmed in both glioma cell lines and glioblastoma multiforme patient specimens. Ectopic Rab3a expression in glioma cell lines and primary astrocytes promoted cell proliferation by increasing cyclin D1 expression, induced resistance to anti-cancer drug and irradiation, and accelerated foci formation in soft agar and tumor formation in nude mice. The overexpression of Rab3a augmented the tumorsphere-forming ability of glioma cells and p53(-/-) astrocytes and increased expression levels of various stem cell markers. Taken together, our results indicate that Rab3a is a novel oncogene involved in glioma initiation and progression. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | CELL GENESIS | - |
dc.subject | STEM-CELL | - |
dc.subject | EXPRESSION | - |
dc.subject | CANCER | - |
dc.subject | DIFFERENTIATION | - |
dc.subject | IDENTIFICATION | - |
dc.subject | GLIOMA | - |
dc.title | Rab3a promotes brain tumor initiation and progression | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Hyunggee | - |
dc.identifier.doi | 10.1007/s11033-014-3465-2 | - |
dc.identifier.scopusid | 2-s2.0-84906938409 | - |
dc.identifier.wosid | 000341089400038 | - |
dc.identifier.bibliographicCitation | MOLECULAR BIOLOGY REPORTS, v.41, no.9, pp.5903 - 5911 | - |
dc.relation.isPartOf | MOLECULAR BIOLOGY REPORTS | - |
dc.citation.title | MOLECULAR BIOLOGY REPORTS | - |
dc.citation.volume | 41 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 5903 | - |
dc.citation.endPage | 5911 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.subject.keywordPlus | CELL GENESIS | - |
dc.subject.keywordPlus | STEM-CELL | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | GLIOMA | - |
dc.subject.keywordAuthor | Glioblastoma multiforme | - |
dc.subject.keywordAuthor | Rab3a | - |
dc.subject.keywordAuthor | Cyclin D1 | - |
dc.subject.keywordAuthor | Gliomagenesis | - |
dc.subject.keywordAuthor | Drug resistance | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.